Matsumoto, H., Shiotani, A. and Graham, D.Y. (2019) Current and Future Treatment of Helicobacter pylori Infections. In: Kamiya, S. and Backert, S., Eds., Helicobacter pylori in Human Diseases, Vol. 1149, Springer, Cham, 211-225.
https://doi.org/10.1007/5584_2019_367

has been cited by the following article:

• TITLE: Assessing of the Therapeutic Efficacy of These 2 Treatment Regimens in the Management of Helicobacter pylori Infection at Kinshasa

  AUTHORS: Antoine Tshimpi, Patrick de Jésus Ngoma-Kisoko, Aurore Beia, Tressy Kalenga-Ngomba, Jacqueline Nkondi, Fabrice Bokabanja, Heritier Mawalala, Trésor Monsere, Pitshou Kengibe, Mireille Nganga Nkanga, Benjamin Longo-Mbenza

  KEYWORDS: Helicobacter pylori, Concomitant Quadruple Therapy, Sequential Quadruple Therapy, Eradication, Kinshasa

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.12 No.3, March 17, 2022

  ABSTRACT: Introduction: Helicobacter pylori (Hp) infection is a worldwide public health problem. Unfortunately, its management poses a problem because of resistance to antibiotics. However, there are codified treatment protocols covering sequential and concomitant quadritherapy with regard to first-line probabilistic treatment. The objective of this study was to assess the therapeutic efficacy of these 2 treatment regimens in the management of Hp infection at Kinshasa. Methods: This was a mixed study, with documentary, descriptive and interventional approaches, carried out between September 1, 2018 and April 30, 2020. Results: Sixty-four patients were collected, including 36 men against 28 women with a sex ratio of 1H:1F; the mean age was 54 ± 16.5 years. There was an over-representation of senior patients (n = 29); an intermediate number of adult patients (n = 22) and a lower number of young patients (n = 13). 34 and 30 were respectively treated according to the concomitant and sequential regimens. Concomitant quadruple therapy offered an eradication rate of 91.2% compared to 56.7% for sequential quadruple therapy; concomitant treatment, advancing age and absence of risky behavior more quickly predicted the occurrence of eradication success. Conclusion: The present study showed superiority of concomitant quadruple therapy over sequential quadruple therapy in first-line treatment. Alcohol with active smoking had a negative influence, while concomitant quadruple therapy, advancement in age had a positive influence on the success of the eradication of Hp infection.